A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 117.81
GOOG 750.26
MSFT 53.93
FB 105.45
BAC 17.48

Recently Added

TITN 12.58
LGIH 32.97
ENSG 47.60
SWN 8.74
CCP 32.09

Gaining Speed

LGIH 32.97
TITN 12.58
OXY 75.19
HCN 63.19
FTNT 36.69

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More

Get Alerted When News Hits On This Stock - FREE!